Better Therapeutics, Inc. (BTTX)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Mar 19, 2026
Market Cap5.45K -99.0%
Revenue (ttm)n/a
Net Income-31.57M
EPS-1.08
Shares Out54.52M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,372
Average Volume6,898
Open0.0002
Previous Close0.0001
Day's Range0.0001 - 0.0002
52-Week Range0.0000 - 0.0010
Beta-43.12
RSI53.15
Earnings DateMar 30, 2026

About Better Therapeutics

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company’s lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company’s clinical development candidates are intended to treat cardiometabolic diseases, incl... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 54
Stock Exchange OTCMKTS
Ticker Symbol BTTX
Full Company Profile

Financial Performance

Financial Statements